MSMaya Sela

Maya Sela

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maya Sela has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Pediatric Heart Listing Mortality score: A score to estimate 12-month waitlist mortality risk in candidates awaiting heart transplant

    by Jose Ramirez, Mahita Maddukuri, Louis Abarca, Arman Kavoussi, Natalie Osterlund, Maya Sela, Abbas Rana

  • Comparative Risk Profiles in the Surgical Management of Pediatric Sialorrhea

    by Maya Sela, Joshua R. Bedwell, Elton M. Lambert

    Objective: Sialorrhea commonly affects patients with neurodevelopmental disorders, resulting in aspiration risk and reduced quality of life. This study aims to compare the risk profiles for the surgical management of pediatric sialorrhea. Methods: A retrospective cohort study was performed using the American College of Surgeons' National Surgical Quality Improvement Program–Pediatric database (2012–2023) of patients undergoing surgery for sialorrhea in the operating room. 30‐day outcomes included medical complications, surgical complications, length of stay, unplanned reintubation, reoperation, readmission, and composite morbidity. Clinically relevant, significant variables on univariate analysis were retained for Firth's logistic regression. Results: Among 295 patients, 23% received botulinum injections (Bot‐Sal), 56% salivary duct ligation or re‐routing (SDL/R), 10% submandibular gland excision alone (SMGE), and 11% combined SMGE + SDL/R. Compared with Bot‐Sal, SDL/R was associated with lower odds of pulmonary complications (OR 0.18, 95% CI 0.06–0.56, p = 0.003), medical complications (OR 0.15, 95% CI 0.05–0.45, p = 0.001), and composite morbidity (OR 0.37, 95% CI 0.15–0.90, p = 0.027). Inpatient status (OR 5.04, 95% CI 1.87–13.62, p = 0.001) and CNS abnormalities (OR 2.70, 95% CI 1.07–6.79, p = 0.035) were independently associated with increased risk of pulmonary complications. There were no significant differences in surgical complications by procedure. Conclusion: Botulinum injections to the salivary glands in the operating room were associated with increased medical complications, specifically pulmonary, in this dataset, likely reflecting a combination of patient selection, clinical context, and procedural factors. Short‐term complication rates may help guide families regarding options for drooling procedures in the OR. Level of Evidence: 3

  • Open Access

    Waiting List Survival Trends in Pediatric Lung Transplantation: A National Cohort Study

    by Elijah Roberts, Maya Sela, Chase Robinson, Zhi Mei Sonia He, Garrett Wortham, Kiran Thirukonda, Rodrigo Zea‐Vera, Abbas Rana, David S. Moreno McNeill

    Background: Advancements in pediatric lung transplantation, including support devices, the Lung Allocation Score (LAS), and the subsequent Composite Allocation Score (CAS), have led to significant improvements in survival on the waiting list. Policy changes, like the removal of the Donation Service Area in 2017, aimed to further improve outcomes, but their impact in more recent years remains unclear. Our study examines recent waiting list survival trends and key factors affecting outcomes for pediatric lung transplant candidates. Methods: Pediatric patients ( n = 535) listed for lung transplantation in the OPTN Database were categorized into four eras based on year of listing: 2014–2017 ( n = 182), 2017–2020 ( n = 174), 2020–March 2023 ( n = 134), and March 2023 onward ( n = 45). Our primary outcome was death on the waiting list. Predictors of waitlist mortality were identified with multivariable logistic regression. Kaplan‐Meier curves with a log‐rank test were used to evaluate outcomes across eras. The Fine and Gray method was used to account for competing outcomes, including transplantation and removal from the waitlist due to clinical improvement. Results: Poor functional status, ventilation at time of listing, African American ethnicity, and listing in region 1 were associated with increased waitlist mortality. One‐year survival increased from 2014–2017 to 2020–2023 ( p < 0.05). When accounting for competing risks, Fine and Gray showed a declining incidence of waitlist mortality with each successive era. Conclusion: Waiting list survival for pediatric lung transplant candidates has improved since 2014, with notable progress in the 2020–2023 era. The reasons for these improvements are likely multifactorial, and further studies are needed to evaluate their impact.

  • Improved outcomes in adult lung transplantation: a two-decade national analysis

    by Maya Sela, Elijah Roberts, Zhi Mei Sonia He, Sophie Li, Kiran Thirukonda, Samantha Sarlin, Jose Ramirez, Ramiro Fernandez, Abbas Rana